Literature DB >> 2104626

Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.

A M Matsumoto1.   

Abstract

In normal men, chronic testosterone (T) administration results in negative feedback suppression of gonadotropin and sperm production. However, azoospermia is achieved in only 50-70% of men treated with high dosages of T. Furthermore, the relative sensitivity of LH and FSH secretion to chronic administration of more physiological dosages of T is unclear. We determined whether a T dosage higher than those previously given would be more or less effective in suppressing spermatogenesis and whether, within the physiological range, T would exert a more selective effect on LH than on FSH secretion. After a 4- to 6-month control period, 51 normal men were randomly assigned to treatment groups (n = 9-12/group) receiving either sesame oil (1 mL) or T enanthate (25, 50, 100, or 300 mg, im) weekly for 6 months. Monthly LH and FSH levels by RIA and twice monthly sperm counts were determined. During treatment, T levels were measured daily between two weekly injections. Chronic T administration in physiological to moderately supraphysiological dosages resulted in parallel dose-dependent suppression of LH, FSH, and sperm production. T enanthate (50 mg/week) suppressed LH and FSH levels and sperm counts to 50% of those in placebo-treated men (ED50). T enanthate (300 mg/week), was no more effective than 100 mg/week in suppressing LH, FSH, and sperm production. Serum T levels in men who received 100 and 300 mg/week T enanthate were 1.5- and 3-fold higher than those in placebo-treated men, respectively. Except for mild truncal acne, weight gain, and increases in hematocrit, we detected no significant adverse health effects of chronic high dosage T administration. We conclude that 1) LH and FSH secretion are equally sensitive to the long term negative feedback effects of T administration; 2) sperm production is suppressed in parallel with the LH and FSH reductions induced by chronic T administration; and 3) even at the clearly supraphysiological dosage of 300 mg/week, T enanthate does not reliably induce azoospermia in normal men. However, there was also no evidence of a stimulatory effect of this T dosage on spermatogenesis. Furthermore, we found no evidence of major adverse health effects of T administered chronically even at the highest dosage.

Entities:  

Keywords:  Americas; Androgens; Biology; Case Control Studies; Clinical Research; Clinical Trials; Contraception; Contraceptive Agents; Contraceptive Agents, Male; Developed Countries; Endocrine System; Evaluation; Evaluation Methodology; Family Planning; Feedback; Follicle Stimulating Hormone--men; Gonadotropins; Gonadotropins, Pituitary; Hormones; Luteinizing Hormone--men; North America; Northern America; Physiology; Research Methodology; Research Report; Spermatogenesis Blocking Agents; Studies; Testosterone--administraction and dosage; United States; Washington

Mesh:

Substances:

Year:  1990        PMID: 2104626     DOI: 10.1210/jcem-70-1-282

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

1.  Biphasic testosterone delivery profile observed with two different transdermal formulations.

Authors:  A Misra; R Pal; S S Majumdar; G P Talwar; O Singh
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

Review 2.  Prospects for pharmacological male contraception.

Authors:  S A Matlin
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

Review 3.  Medical treatment of erectile dysfunction.

Authors:  N Burns-Cox; C Gingell
Journal:  Postgrad Med J       Date:  1998-06       Impact factor: 2.401

4.  U.S. National Football League athletes seeking unproven stem cell treatments.

Authors:  Kirstin R W Matthews; Maude L Cuchiara
Journal:  Stem Cells Dev       Date:  2014-12       Impact factor: 3.272

Review 5.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

Review 6.  The andropause: fact or fiction?

Authors:  N Burns-Cox; C Gingell
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

7.  Effects of high doses of testosterone propionate and testosterone enanthate on rat seminiferous tubules--a stereological and cytological study.

Authors:  D Jezek; L Simunić-Banek; R Pezerović-Panijan
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

Review 8.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

9.  Men with acquired hypogonadotropic hypogonadism treated with testosterone may be fertile.

Authors:  Andjela Drincic; Onur Karamanoglu Arseven; Ernesto Sosa; Moises Mercado; Peter Kopp; Mark E Molitch
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

10.  Effects of benzo(a)pyrene on intra-testicular function in F-344 rats.

Authors:  Anthony E Archibong; Aramandla Ramesh; Mohammad S Niaz; Cynthia M Brooks; Shannon I Roberson; Donald D Lunstra
Journal:  Int J Environ Res Public Health       Date:  2008-03       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.